Poly Implant Prothèse
Poly Implant Prothèse (PIP) was a French company founded in 1991 that produced silicone breast implants. The company came to international attention in 2010 when it was discovered that they had been manufacturing implants using industrial-grade silicone rather than medical-grade silicone, leading to a global health scare and a scandal over regulatory oversight of medical devices.
History
Poly Implant Prothèse was established in the south of France and quickly became one of the world's leading producers of silicone breast implants. By the late 2000s, PIP implants were among the most popular choices for breast augmentation and reconstructive surgery following mastectomy. However, the company's success was marred by controversy when it was revealed that they had been using cheaper, industrial-grade silicone in their implants, which was not approved for medical use and had a higher risk of rupturing and causing inflammation in the body.
Scandal
The scandal emerged in 2010 after surgeons and patients reported an unusually high rate of implant ruptures. Investigations revealed that PIP had been deliberately using non-medical grade silicone to reduce costs. This silicone was found to have a significantly higher rupture rate compared to implants made with medical-grade materials. The revelation led to widespread panic among patients and a rush to have the implants removed or replaced.
Regulatory Response
The discovery of PIP's practices led to a global response from medical and regulatory bodies. Many countries issued recalls or advised women with PIP implants to have them checked or removed. The European Union and other regulatory bodies around the world tightened regulations on medical devices, requiring more stringent testing and certification processes to prevent similar incidents.
Legal Proceedings
Jean-Claude Mas, the founder of PIP, was arrested and charged with fraud and involuntary manslaughter. In 2013, he was convicted and sentenced to four years in prison. The company was also liquidated, and several executives were fined and given prison sentences. Additionally, thousands of women who had received PIP implants filed lawsuits seeking compensation for the harm they suffered.
Impact
The PIP scandal had a profound impact on the breast implant industry and on regulations governing medical devices. It highlighted the need for more rigorous oversight and testing of medical products and led to increased scrutiny of manufacturers. The scandal also raised awareness about the risks associated with cosmetic surgery and the importance of using high-quality, medically approved materials.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD